| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,404 | 0,440 | 12.09. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | ORBUSNEICH (06929): INTERIM REPORT 2026 | 1 | HKEx | ||
| 17.08. | ORBUSNEICH (06929): CHANGE OF OFFICERS AND COMPANY SECRETARY | 1 | HKEx | ||
| 14.08. | ORBUSNEICH (06929): DECLARATION OF INTERIM DIVIDEND AND CLOSURE OF REGISTER OF MEMBERS (UPDATED) | 1 | HKEx | ||
| 13.08. | OrbusNeich Medical Group Holdings Limited: OrbusNeich Reports Growth Across All Geographies in 2026 Interim Results | 2.634 | JCN Newswire | - Revenue Up 18.1% to US$98.7 Million- Net Profit Rises to US$21.6 Million- Declares First Interim Dividend of HK8 Cents Per ShareHONG KONG, Aug 13, 2026 - (ACN Newswire) - Results Highlights:- Revenue... ► Artikel lesen | |
| 13.08. | OrbusNeich Medical Group Holdings Limited H1 Profit Climbs | 5 | RTTNews | ||
| 13.08. | ORBUSNEICH (06929): DECLARATION OF INTERIM DIVIDEND AND CLOSURE OF REGISTER OF MEMBERS | 6 | HKEx | ||
| 13.08. | ORBUSNEICH (06929): ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2026 | 2 | HKEx | ||
| 31.07. | ORBUSNEICH (06929): DATE OF BOARD MEETING | 1 | HKEx | ||
| ORBUSNEICH MEDICAL GROUP Aktie jetzt für 0€ handeln | |||||
| 24.07. | OrbusNeich Medical Group Holdings Limited: OrbusNeich Announces Enrollment of First Patient in Japan Clinical Trial for its Proprietary Drug-Coated Balloon | 708 | JCN Newswire | HONG KONG, July 22, 2026 - (ACN Newswire) - OrbusNeich Medical Group Holdings Limited ('OrbusNeich' or the 'Group' stock code: 6929), a multinational medical device company specializing in interventional... ► Artikel lesen | |
| 22.07. | ORBUSNEICH (06929): VOLUNTARY ANNOUNCEMENT - FIRST PATIENT ENROLLMENT IN JAPAN CLINICAL TRIAL FOR ITS PROPRIETARY DRUG-COATED BALLOON | 1 | HKEx | ||
| 09.06. | XFRA CAPITAL ADJUSTMENT INFORMATION - 09.06.2026 | 855 | Xetra Newsboard | Das Instrument G85 CA35958L1013 FUERTE METALS CORP. EQUITY wird cum Kapitalmassnahme gehandelt am 09.06.2026 und ex Kapitalmassnahme am 10.06.2026 The instrument G85 CA35958L1013 FUERTE METALS CORP.... ► Artikel lesen | |
| 08.06. | ORBUSNEICH (06929): (1) POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 8, 2026 AND (2) PAYMENT OF FINAL DIVIDEND | 1 | HKEx | ||
| 13.04. | ORBUSNEICH (06929): REMINDER LETTER TO NON-REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF 2025 ANNUAL REPORT AND CIRCULAR INCLUDING NOTICE OF ANNUAL ... | 1 | HKEx | ||
| 13.04. | ORBUSNEICH (06929): REMINDER LETTER TO REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF 2025 ANNUAL REPORT, CIRCULAR INCLUDING NOTICE OF ANNUAL GENERAL ... | - | HKEx | ||
| 13.04. | ORBUSNEICH (06929): FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON JUNE 8, 2026 | - | HKEx | ||
| 13.04. | ORBUSNEICH (06929): NOTICE OF ANNUAL GENERAL MEETING | - | HKEx | ||
| 13.04. | ORBUSNEICH (06929): (1) PROPOSED RE-ELECTION OF RETIRING DIRECTORS, (2) PROPOSED GRANT OF GENERAL MANDATES TO ISSUE SHARES AND TO REPURCHASE SHARES, (3) ... | - | HKEx | ||
| 13.04. | ORBUSNEICH (06929): ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2025 | 2 | HKEx | ||
| 13.04. | ORBUSNEICH (06929): ANNUAL REPORT 2025 | 2 | HKEx | ||
| 12.03. | OrbusNeich Medical Group Holdings Limited: OrbusNeich Achieves Record-breaking Revenue, Sales Volume and Gross Profit in FY2025, Net Profit Rises to US$42 million, Final Dividend Increases by 20% to HK12 Cents per Share | 808 | JCN Newswire | - Sharpens Competitive Edge in Commercialization and Product Innovation- While Exploring New Business Models for Sustainable GrowthHONG KONG, Mar 12, 2026 - (ACN Newswire) - Results Highlights:- Revenue... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TENON MEDICAL | 5,850 | -1,35 % | Tenon Medical Announces Warrant Inducement for Aggregate Gross Proceeds of Approximately $2,872,338 | LOS GATOS, CA / ACCESS Newswire / September 11, 2026 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain... ► Artikel lesen | |
| FRESENIUS | 45,040 | +0,75 % | EQS-DD: Fresenius SE & Co. KGaA: Michael Sen, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
08.09.2026 / 11:02... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,230 | -0,49 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,440 | -0,13 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| PROGYNY | 27,350 | 0,00 % | Progyny auf Gesundheitskonferenz von Wells Fargo: Wachstumsperspektiven bleiben intakt | ||
| BRIGHTSPRING HEALTH SERVICES | 58,73 | 0,00 % | BTSG Gains More Than 54% YTD: Should You Buy, Hold or Sell? | ||
| LIFESTANCE HEALTH GROUP | 12,975 | +0,04 % | LifeStance Health Group, Inc. - 8-K, Current Report | ||
| HEARTFLOW | 49,850 | -0,06 % | Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half | FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 12,610 | 0,00 % | Alignment Healthcare USA, LLC: Alignment Health's Fifth Annual Survey Finds Seniors Falling Further Behind: Aging in Place Challenges Continue to Rise as Support Gaps Widen | ||
| CARL ZEISS MEDITEC | 30,300 | -2,38 % | 411 Milliarden US-Dollar Schaden pro Jahr: Warum Augengesundheit für Carl Zeiss Meditec, Alcon & Co. zum Technologiemarkt wird - und wo Rise Nano Optics ins Spiel kommt | ||
| AVEANNA HEALTHCARE | 14,060 | -0,14 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 20,370 | -0,15 % | Oppenheimer reiterates Procept BioRobotics stock rating | ||
| GERRESHEIMER | 28,220 | -2,62 % | EQS-DD: Gerresheimer AG: Active Ownership Opportunities SCS, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
07.09.2026 / 15:24... ► Artikel lesen | |
| GENEDX | 85,16 | -0,12 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| PRIVIA HEALTH GROUP | 20,420 | 0,00 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen |